Zhao Yi Wang
Fondatore presso Beijing Shenogen Pharma Group Ltd.
Posizioni attive di Zhao Yi Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 01/06/2014 | - |
Direttore Tecnico/Scientifico/R&S | 01/06/2014 | - | |
Fondatore | 01/01/2006 | - |
Storia della carriera di Zhao Yi Wang
Formazione di Zhao Yi Wang
University of Washington | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Cina | 2 |
Posizioni
Doctorate Degree | 1 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Zhao Yi Wang
- Esperienza